RMC No. 47-2022: VAT-Exempt COVID-19 Medicines Under the CREATE Act and FDA-Endorsed Updates for Philippine Taxpayers

RMC No. 47-2022 publishes FDA-endorsed updates adding certain COVID-19 treatment medicines to the CREATE Act VAT-exempt medicines list. Businesses selling, purchasing, prescribing, distributing, or accounting for COVID-19 treatment medicines must check whether the medicine is covered by the FDA-endorsed updates to the list of VAT-exempt medicines under the CREATE Act, because covered medicines should be […]

RMC No. 123-2021: Updated VAT-Exempt COVID-19 Medicines and Vaccine List for Pharmacies, Importers, Hospitals, and Healthcare Suppliers

RMC No. 123-2021 updates the VAT-exempt COVID-19 medicines and vaccine list, affecting pharmacies, hospitals, importers, and healthcare suppliers. Pharmacies, hospitals, healthcare suppliers, importers, distributors, wholesalers, and retailers dealing in COVID-19 medicines must immediately check their product master lists, invoices, point-of-sale systems, and importation records against the updated VAT-exempt list published under RMC No. 123-2021. The […]